Prostate Cancer Screening With cPSA Test Would Reduce Biopsies – Study
This article was originally published in The Gray Sheet
Complexed prostate specific antigen (cPSA) test adoption would reduce the number of unnecessary biopsies, according to a study presented May 27 at the American Urological Association meeting in Orlando
You may also be interested in...
The U.S. Preventive Services Task Force will no longer recommend against routine prostate cancer screening, but cautions that the benefits have not been fully demonstrated
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.